1. Home
  2. ALRN vs INTT Comparison

ALRN vs INTT Comparison

Compare ALRN & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRN
  • INTT
  • Stock Information
  • Founded
  • ALRN 2001
  • INTT 1981
  • Country
  • ALRN United States
  • INTT United States
  • Employees
  • ALRN N/A
  • INTT N/A
  • Industry
  • ALRN Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • ALRN Health Care
  • INTT Technology
  • Exchange
  • ALRN Nasdaq
  • INTT Nasdaq
  • Market Cap
  • ALRN 76.9M
  • INTT 91.4M
  • IPO Year
  • ALRN 2017
  • INTT 1997
  • Fundamental
  • Price
  • ALRN $1.97
  • INTT $8.87
  • Analyst Decision
  • ALRN Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • ALRN 1
  • INTT 2
  • Target Price
  • ALRN $19.00
  • INTT $16.00
  • AVG Volume (30 Days)
  • ALRN 137.2K
  • INTT 43.5K
  • Earning Date
  • ALRN 11-14-2024
  • INTT 11-01-2024
  • Dividend Yield
  • ALRN N/A
  • INTT N/A
  • EPS Growth
  • ALRN N/A
  • INTT N/A
  • EPS
  • ALRN N/A
  • INTT 0.22
  • Revenue
  • ALRN N/A
  • INTT $121,971,000.00
  • Revenue This Year
  • ALRN N/A
  • INTT $7.31
  • Revenue Next Year
  • ALRN N/A
  • INTT $5.77
  • P/E Ratio
  • ALRN N/A
  • INTT $39.83
  • Revenue Growth
  • ALRN N/A
  • INTT N/A
  • 52 Week Low
  • ALRN $1.61
  • INTT $6.28
  • 52 Week High
  • ALRN $7.42
  • INTT $14.35
  • Technical
  • Relative Strength Index (RSI)
  • ALRN 41.44
  • INTT 56.68
  • Support Level
  • ALRN $1.90
  • INTT $8.06
  • Resistance Level
  • ALRN $2.17
  • INTT $9.06
  • Average True Range (ATR)
  • ALRN 0.18
  • INTT 0.45
  • MACD
  • ALRN 0.02
  • INTT -0.02
  • Stochastic Oscillator
  • ALRN 23.27
  • INTT 47.37

About ALRN Aileron Therapeutics Inc.

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Share on Social Networks: